Dafna Capital Management LLC Genfit S.A. Transaction History

Dafna Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.53 - $4.39 $35,300 - $43,900	10,000 Added 5.32%	197,940 $868,000
Q1 2022 May 16, 2022	BUY	$3.14 - $5.04 $400,324 - $642,559	127,492 Added 210.91%	187,940 $752,000
Q4 2021 Feb 14, 2022	SELL	$3.01 - $5.65 $385,584 - $723,770	-128,101 Reduced 67.94%	60,448 $302,000
Q1 2021 May 17, 2021	BUY	$4.53 - $6.06 $336,162 - $449,700	74,208 Added 64.9%	188,549 $871,000
Q4 2020 Feb 16, 2021	BUY	$3.63 - $5.6 $415,057 - $640,309	114,341 New	114,341 $549,000

76.8K

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $207M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.